[1] Briganti SI, Gaspa G, Tabacco G, et al.Irisin as a regulator of bone and glucose metabolism[J].Minerva Endocrinol, 2018, 43(4): 489-500. [2] Liu S, Cui F, Ning K, et al.Role of irisin in physiology and pathology[J].Front Endocrinol (Lausanne), 2022, 13: 962968. [3] 李辉, 宗心南, 季成叶,等.中国2~18岁儿童青少年超重和肥胖筛查体重指数界值点的研究[J].中华流行病学杂志, 2010, 31(6): 616-620. Li H, Zong XN, Ji CY, et al.A study on the cutoff pointsof body mass index for screening overweight and obesity in children and adolescents aged 2-18 in China[J].Chin J Epidemiol, 2010, 31(6): 616-620.(in Chinese) [4] Luo Y, Qiao X, Ma Y, et al.Disordered metabolism in mice lacking irisin[J].Sci Rep, 2020, 10(1): 17368. [5] De Meneck F, de Souza LV, Brioschi ML, et al.Emerging evidence for the opposite role of circulating irisin levels and brown adipose tissue activity measured by infrared thermography in anthropometric and metabolic profile during childhood[J].J Therm Biol, 2021, 99: 103010. [6] De Meneck F, Victorino de Souza L, Oliveira V, et al.High irisin levels in overweight/obese children and its positive correlation with metabolic profile, blood pressure, and endothelial progenitor cells[J].Nutr Metab Cardiovasc Dis, 2018, 28(7): 756-764. [7] Dokumacioglu E, Iskender H, Sahin A, et al.Serum levels of nesfatin-1 and irisin in obese children[J].Eur Cytokine Netw, 2020, 31(1): 39-43. [8] Shim YS, Kang MJ, Yang S, et al.Irisin is a biomarker for metabolic syndrome in prepubertal children[J].Endocr J, 2018, 65(1): 23-31. [9] Elizondo-Montemayor L, Mendoza-Lara G, Gutierrez-DelBosque G, et al.Relationship of circulating irisin with body composition, physical activity, and cardiovascular and metabolic disorders in the pediatric population[J].Int J Mol Sci, 2018, 19(12). [10] Maak S, Norheim F, Drevon CA, et al.Progress and challenges in the biology of FNDC5 and irisin[J].Endocr Rev, 2021, 42(4): 436-456. [11] Witkowska-Sędek E, Kucharska A, Rumińska M, et al.Thyroid dysfunction in obese and overweight children[J].Endokrynol Pol, 2017, 68(1): 54-60. [12] Song RH, Wang B, Yao QM, et al.The impact of obesity on thyroid autoimmunity and dysfunction: A systematic review and meta-analysis[J].Front Immunol, 2019, 10: 2349. [13] Lu D, Yuan Z, Gao Y, et al.Central obesity is associated with variations in TSH and ACTH levels among euthyroid obese individuals[J].Int J Endocrinol, 2022, 2022: 3830380. [14] de Oliveira M, Mathias LS, Rodrigues BM, et al.The roles of triiodothyronine and irisin in improving the lipid profile and directing the browning of human adipose subcutaneous cells[J].Mol Cell Endocrinol, 2020, 506: 110744. [15] Sentis SC, Oelkrug R, Mittag J.Thyroid hormones in the regulation of brown adipose tissue thermogenesis[J].Endocr Connect, 2021, 10(2): 106-115. [16] Leustean L, Preda C, Teodoriu L, et al.Role of Irisin in endocrine and metabolic disorders—possible new therapeutic agent?[J].Applied Sciences, 2021, 11(12): 5579. [17] Tekin S, Erden Y, Ozyalin F, et al.Central irisin administration suppresses thyroid hormone production but increases energy consumption in rats[J].Neuroscience letters, 2018, 674: 136-141. [18] Samy DM, Ismail CA, Nassra RA.Circulating irisin concentrations in rat models of thyroid dysfunction-effect of exercise[J].Metabolism, 2015, 64(7): 804-813. |